Search research articles
Contact Us
Filters
Showing results (331-340 of 399) with videos related to
Page
of 40
Sort By:
International Urology and Nephrology
|
January 19, 2022
Prognostic value of metabolic syndrome in renal structural changes in type 2 diabetes
Lijun Zhao, Yutong Zou, Lin Bai, et al.
JAMA
|
September 2, 2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial
George L Bakris, Rajiv Agarwal, Juliana C Chan, et al.
Kidney International
|
May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy
Sally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Frontiers in Physiology
|
June 26, 2020
Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease
Anna M D Watson, Eleanor A M Gould, Sarah C Moody, et al.
Diabetes Research and Clinical Practice
|
June 9, 2012
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes
Susan van Dieren, Andre P Kengne, John Chalmers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 22, 2026
Mitochondrial Alterations and CKD
Jairo A Pinzon-Cortes, Phoom Narongkiatikhun, Long Yuan, et al.
Journal of Medicinal Chemistry
|
June 17, 2021
Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A<sub>4</sub> Mimetics (QNX-sLXms)
Monica de Gaetano, Catherine Tighe, Kevin Gahan, et al.
Diabetes Research and Clinical Practice
|
September 25, 2023
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitus
Ishant Khurana, Natasha J Howard, Scott Maxwell, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study
William F Keane, Zhongxin Zhang, Paulette A Lyle, et al.
Diabetes Care
|
March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Muh Geot Wong, Vlado Perkovic, John Chalmers, et al.
Page
of 40
Search research articles
Search
Showing results (331-340 of 399) with videos related to
Sort By:
Page
of 40
International Urology and Nephrology
|
January 19, 2022
Prognostic value of metabolic syndrome in renal structural changes in type 2 diabetes
Lijun Zhao, Yutong Zou, Lin Bai, et al.
JAMA
|
September 2, 2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial
George L Bakris, Rajiv Agarwal, Juliana C Chan, et al.
Kidney International
|
May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy
Sally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Frontiers in Physiology
|
June 26, 2020
Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease
Anna M D Watson, Eleanor A M Gould, Sarah C Moody, et al.
Diabetes Research and Clinical Practice
|
June 9, 2012
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes
Susan van Dieren, Andre P Kengne, John Chalmers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 22, 2026
Mitochondrial Alterations and CKD
Jairo A Pinzon-Cortes, Phoom Narongkiatikhun, Long Yuan, et al.
Journal of Medicinal Chemistry
|
June 17, 2021
Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A<sub>4</sub> Mimetics (QNX-sLXms)
Monica de Gaetano, Catherine Tighe, Kevin Gahan, et al.
Diabetes Research and Clinical Practice
|
September 25, 2023
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitus
Ishant Khurana, Natasha J Howard, Scott Maxwell, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study
William F Keane, Zhongxin Zhang, Paulette A Lyle, et al.
Diabetes Care
|
March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Muh Geot Wong, Vlado Perkovic, John Chalmers, et al.
Page
of 40